Executive Profile

Robert Alexander Ingram General Partner, Hatteras Venture Partners

Age	Total Calculated Compensation	This person is connected to 15 Board Members in 15 different organizations across 21 different industries. See Board Relationships
69	--

Background

Mr. Robert Alexander Ingram, Bob, serves as General Partner at Hatteras Venture Partners since January 24, 2007. Mr. Ingram serves as Special Advisor to Chairman, Chief Executive Officer, and President at Jennerex Biotherapeutics, Inc. Mr. Ingram served as an Advisor to the Chief Executive Officer at GlaxoSmithKline plc since January 2010. He served as a Special Consultant at GlaxoSmithKline plc and served as its Vice Chairman of Pharmaceuticals since January 2003 till ... January 1, 2010 at which time he became Strategic Advisor to the Chief Executive Officer, GlaxoSmithKline plc. Mr. Ingram served as the Chief Operating Officer and President of Pharmaceutical Operations at GlaxoSmithKline PLC (GSK) from January 2001 to January 2003 and acting as a special advisor to the Corporate Executive Team and attending its meetings from January 2003 to December 2009. Mr. Ingram served as the Chairman, President, and Chief Executive Officer at Glaxo Wellcome PLC from October 1997 to January 1999 and Chief Executive Officer at Glaxo Wellcome Inc. from 1994 to January 1999. He began his career in the pharmaceutical industry as a sales representative at OSI Pharmaceuticals Inc., which would later become Merrell Dow Pharmaceuticals. Mr. Ingram co-leads the merger and integration that formed GlaxoSmithKline. He advanced rapidly through sales management at Merrell Dow and into government and public affairs. Mr. Ingram left Merrell Dow in 1985 as Vice President of Public Affairs. He served as the Vice President of Government Affairs at Merck & Co. Inc. since 1985. Since 1988, Mr. Ingram served as President at Merck Frosst Canada Inc. In 1990, he joined Glaxo Inc., Glaxo plc's U.S. subsidiary, as Executive Vice President of Administrative and Regulatory Affairs and assumed a series of increasingly responsible positions, including Group Vice President. Mr. Ingram served as an Executive Vice President since January 1993, Chief Operating Officer and President since June 1993, Chief Executive Officer since March 1994 and Chairman since January 1999 of Glaxo Inc. Mr. Ingram has been the Non-Executive Chairman and Member of the Board of Directors at Elan Corporation, plc since January 26, 2011. He is also a Lead Director since March 2011, Director since September 28, 2010, and served as the Chairman of Valeant Pharmaceuticals International, Inc. from August 2006 to February 1, 2008. Mr. Ingram serves as a Director of HBM Partners. He has been a Member of the Board of Directors Cree Inc. since December 29, 2008; Quintiles Transnational Corp. since March 1, 2004; and Elan Corp. plc since December 6, 2010. Mr. Ingram is a Member of the Board of Directors of HBM Healthcare Investments AG. He serves as a Member of Strategic Advisory Board of Audax Health Solutions Inc. Mr. Ingram serves as a Director of Jim “Catfish“ Hunter Chapter of ALS Association. He serves as a Director of PhaseBio Pharmaceuticals, Inc. Mr. Ingram serves as a Director of TheraCom, Inc. and Project Hope. He is a Member of the Boards for GlaxoSmithKline Foundation. He serves as Member of the International Advisory Council at Chugai Pharmaceutical Co. Ltd. Mr. Ingram is a Member of the Board of Advisors for the H. Lee Moffitt Cancer Center and Research Institute. He has been a Director of Pharmaceutical Product Development Inc. since May 18, 2011. he has been a Director of Wachovia Corp. since 1997. He has been an Independent Director of Edwards Lifesciences Corp. since February 20, 2003. Mr. Ingram is a Board Member of Research Triangle Institute. He served as a Director of Allergan Inc. from January 25, 2005 to December 10, 2012. Mr. Ingram is a member of the boards for the James B. Hunt Jr. Institute for Educational Leadership and Policy, H. Lee Moffitt Cancer Center, and CEO Roundtable on Cancer. He served as the Chairman of the Board of Trustees of the American Cancer Society Foundation, and American Cancer Society, Inc. Mr. Ingram served as a Director of Lowe's Companies Inc. from 2001 to May 27, 2011. He served as a Director of Partnership for Public Service. Mr. Ingram served as a Director and Non Executive Chairman of OSI Pharmaceuticals Inc. since January 1, 2003. He served as a Director of Molson Inc. from June 19, 2002 to July 28, 2004. Mr. Ingram served as an Independent Director of Nortel Networks Corp. from March 7, 2000 to June 29, 2006 and Nortel Networks Ltd. from April 29, 1999 to June 29, 2006. He served as the Chairman of Glaxo Wellcome Inc., Glaxo Wellcome PLC's U.S. subsidiary, from January 1999 to December 2000. Mr. Ingram served as Director of Wachovia Securities, Inc. since 1997. He served as Director of Nortel Networks Netas Telekomunikasyon AS. Mr. Ingram served as a Director of Wells Fargo Bank, N.A., Charlotte (Wachovia Bank, National Association (Charlotte, NC)). He served as Non-Executive Director of Misys PLC from January 2002 to September 13, 2005. Mr. Ingram served as Executive Director of Glaxo Wellcome PLC from September 1996 to October 1997. He is frequent speaker at industry, pharmacy, and government seminars. In January 2004, Mr. Ingram was awarded the Martin Luther King, Jr. Legacy Award for International Service. On July 27, 2006, he was appointed by President George W. Bush to the National Institutes of Health, National Cancer Advisory Board. Mr. Ingram was asked by former U.S. President George H. Bush to form and Chair the Chief Executive Officer of Roundtable on Cancer. He serves as Chairman of Research Triangle Foundation of North Carolina and is on the Advisory Board, Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California. Mr. Ingram graduated from Eastern Illinois University, Lumpkin College of Business, Charleston, Illinois in 1965 with a B.Sc. degree in Business Administration.

Corporate Headquarters 280 South Mangum Street Durham, North Carolina 27701 United States Phone: 919-484-0730 Fax: 919-484-0364 Board Members Memberships Former Chairman of Board of Trustees American Cancer Society, Inc. Director Wells Fargo Bank, N.A., Charlotte Director PhaseBio Pharmaceuticals, Inc. Director HBM Partners Ltd. Director Partnership for Public Service 1997-Present Independent Director, Chairman of Corporate Governance & Nominating Committee, Member of Management Resources & Compensation Committee, Member of Executive Committee and Member of Search Committee Wachovia Corporation 1997-N/A Former Director Wachovia Corp., Prior to the acquisition by First Union Corporation 1997-N/A Director Wachovia Securities, Inc, prior to being acq. by First Union 1999-2006 Former Director and Director of Nortel Networks Corporation Nortel Networks Ltd. 2000-N/A Former Independent Director, Chairman of Nominating & Governance Committee, Chairman of Committee on Directors, Member of Audit Committee and Director of Nortel Networks Limited Nortel Networks Corp. 2001-2011 Former Director, Member of Governance Committee and Member of Compensation Committee Lowe's Companies Inc. 2002-2004 Former Director Molson Inc. 2002-2005 Former Non Executive Director Misys plc 2003-N/A Former Lead Director, Member of Corporate Governance/ Nominating Committee and Member of Compensation Committee Valeant Pharmaceuticals International 2003-N/A Former Chairman, Chairman of Corporate Governance & Nominating Committee, Chairman of Executive Committee and Member of Compensation Committee OSI Pharmaceuticals Inc. 2003-Present Independent Director and Member of Compensation & Governance Committee Edwards Lifesciences Corp. 2004-Present Director, Chairman of Compensation and Nominations Committee and Member of Quality/ Regulatory Committee Quintiles Transnational Corp. 2005-2012 Former Director and Member of Organization & Compensation Committee Allergan Inc. 2005-Present Member of the Board of Directors and Member of the Nominating Committee HBM Healthcare Investments AG 2008-Present Director, Chairman of Governance & Nominations Committee and Member of Compensation Committee Cree, Inc. 2010-Present Non-Executive Chairman and Member of Nominating & Governance Committee Elan Corporation, plc 2010-Present Lead Director and Member of Talent & Compensation Committee Valeant Pharmaceuticals International, Inc. 2011-Present Director Pharmaceutical Product Development, LLC Education BS 1965 Eastern Illinois University Other Affiliations Quintiles Transnational Corp. Pharmaceutical Product Development, LLC Valeant Pharmaceuticals International Nortel Networks Corp. American Cancer Society, Inc. Wachovia Corporation Lowe's Companies Inc. Wachovia Corp., Prior to the acquisition by First Union Corporation Cree, Inc. Allergan Inc. Elan Corporation, plc GlaxoSmithKline plc OSI Pharmaceuticals Inc. Valeant Pharmaceuticals International, Inc. Edwards Lifesciences Corp. Chugai Pharmaceutical Co. Ltd. Molson Inc. Misys plc HBM Healthcare Investments AG Research Triangle Institute Wells Fargo Bank, N.A., Charlotte Nortel Networks Ltd. PhaseBio Pharmaceuticals, Inc. Eastern Illinois University Wachovia Securities, Inc, prior to being acq. by First Union HBM Partners Ltd. Partnership for Public Service Prosidion Limited ALS Association Jennerex Biotherapeutics, Inc. Hatteras Venture Partners III, L.P. Audax Health Solutions Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.